Fluoxetine Supplier-Buyer Network — Trade Flow Analysis

Name: Fluoxetine Supplier-Buyer Trade Network Dataset — 253+ Indian Exporters, 16+ Importers, 101+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Fluoxetine supplier network, Fluoxetine buyers, pharmaceutical export India, Fluoxetine trade data

TransData Nexus

Fluoxetine

India Pharmaceutical Trade Intelligence

$235.3M253 Suppliers101 CountriesHS 30049099

ExportsIndia → UNITED STATES65.6%India → CANADA12.9%

ImportsUNITED KINGDOM → India$6.7B GERMANY → India$738.6K

#1 Supplier: SIDMAK LABORATORIES

Who Supplies Fluoxetine? Top Manufacturers & Buyers 2026 — SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED Leads | TransData Nexus | TransData Nexus

1SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED

SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED is the first-largest Fluoxetine exporter from India, with a market share of 48.2% and a total export value of $113.3M across 99 shipments. Their average shipment value of $1.1M is above the market average of $63.6K, suggesting premium or bulk contract pricing.

SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED serves 4 named buyers in our database. AVET PHARMACEUTICALS INC C/O is the dominant customer, accounting for 99.5% of this supplier's tracked business. Top customers include:

• AVET PHARMACEUTICALS INC C/O — $112.8M across 99 shipments (99.5% of this supplier's total exports)

• AVET PHARMACEUTICALS INC C/O — $268.0K across 0 shipments (0.2% of this supplier's total exports)

• AVET PHARMACEUTICALS INC C/O — $123.4K across 0 shipments (0.1% of this supplier's total exports)

• AVET PHARMACEUTICALS INC C/O — $121.9K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED's per-shipment value of $1.1M is 1701% above the market average of $63.6K, consistent with large-order contracts or value-added formulations.

2INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the second-largest Fluoxetine exporter from India, with a market share of 12.0% and a total export value of $28.2M across 97 shipments. Their average shipment value of $290.7K is above the market average of $63.6K, suggesting premium or bulk contract pricing.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. ACCORD HEALTHCARE INC., is the dominant customer, accounting for 90.1% of this supplier's tracked business. Top customers include:

• ACCORD HEALTHCARE INC., — $25.4M across 87 shipments (90.1% of this supplier's total exports)

• ACCORD HEALTHCARE INC., — $2.4M across 8 shipments (8.6% of this supplier's total exports)

• ACCORD HEALTHCARE INC., — $197.7K across 1 shipments (0.7% of this supplier's total exports)

• JAMP PHARMA CORPORAT — $127.0K across 0 shipments (0.5% of this supplier's total exports)

• ACCORD HEALTHCARE INC., — $58.8K across 0 shipments (0.2% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $290.7K is 357% above the market average of $63.6K, consistent with large-order contracts or value-added formulations.

3MICRO LABS LIMITED

MICRO LABS LIMITED is the third-largest Fluoxetine exporter from India, with a market share of 8.8% and a total export value of $20.8M across 154 shipments. Their average shipment value of $135.1K is above the market average of $63.6K, suggesting premium or bulk contract pricing.

MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• BROWN AND BURK LIMITED — $10.4M across 77 shipments (50.0% of this supplier's total exports)

• IMRES B.V. — $8.8M across 65 shipments (42.1% of this supplier's total exports)

• TEVA 3PL WAREHOUSE ( — $751.7K across 6 shipments (3.6% of this supplier's total exports)

• IMPERIAL MEDICAL SOL — $482.1K across 4 shipments (2.3% of this supplier's total exports)

• ARROW PHARMACEUTICAL — $420.7K across 3 shipments (2.0% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED's per-shipment value of $135.1K is 113% above the market average of $63.6K, consistent with large-order contracts or value-added formulations.

4AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the fourth-largest Fluoxetine exporter from India, with a market share of 3.2% and a total export value of $7.6M across 232 shipments. Their average shipment value of $32.9K is below the market average of $63.6K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ORION CORPORATION, — $3.0M across 92 shipments (39.6% of this supplier's total exports)

• APL SWIFT SERVICES (MALTA) LTD., — $1.9M across 58 shipments (25.1% of this supplier's total exports)

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $1.2M across 36 shipments (15.5% of this supplier's total exports)

• AUROLOGISTICS LLC (AUROBINDO PHARMA — $855.2K across 26 shipments (11.2% of this supplier's total exports)

• AUROLOGISTICS LLC, ( — $658.5K across 20 shipments (8.6% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (232 shipments) at a per-shipment value of $32.9K, indicating a broad distribution network with many smaller, regular orders.

5TORRENT PHARMACEUTICALS LTD

TORRENT PHARMACEUTICALS LTD is the fifth-largest Fluoxetine exporter from India, with a market share of 2.0% and a total export value of $4.6M across 39 shipments. Their average shipment value of $119.2K is above the market average of $63.6K, suggesting premium or bulk contract pricing.

TORRENT PHARMACEUTICALS LTD serves 4 named buyers in our database. TORRENT PHARMA INC, is the dominant customer, accounting for 91.2% of this supplier's tracked business. Top customers include:

• TORRENT PHARMA INC, — $4.2M across 36 shipments (91.2% of this supplier's total exports)

• TORRENT PHARMA INC, — $405.3K across 3 shipments (8.7% of this supplier's total exports)

• PHARMACEUTICAL AND C — $4.7K across 0 shipments (0.1% of this supplier's total exports)

• PHARMACEUTICAL AND C — $975 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: TORRENT PHARMACEUTICALS LTD's per-shipment value of $119.2K is 88% above the market average of $63.6K, consistent with large-order contracts or value-added formulations.

6ALEMBIC PHARMACEUTICALS LIMITED

ALEMBIC PHARMACEUTICALS LIMITED is the fifth-largest Fluoxetine exporter from India, with a market share of 1.6% and a total export value of $3.8M across 261 shipments. Their average shipment value of $14.6K is below the market average of $63.6K, reflecting a high-volume, competitive pricing strategy.

ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. J. KNIPPER & COMPANY is the dominant customer, accounting for 52.4% of this supplier's tracked business. Top customers include:

• J. KNIPPER & COMPANY — $2.0M across 137 shipments (52.4% of this supplier's total exports)

• J. KNIPPER & COMPANY — $980.4K across 67 shipments (25.7% of this supplier's total exports)

• J. KNIPPER & COMPANY — $342.9K across 24 shipments (9.0% of this supplier's total exports)

• J. KNIPPER & COMPANY — $303.0K across 21 shipments (8.0% of this supplier's total exports)

• MINT PHARMACEUTICAL — $186.6K across 13 shipments (4.9% of this supplier's total exports)

Key Insight: ALEMBIC PHARMACEUTICALS LIMITED operates with high shipment frequency (261 shipments) at a per-shipment value of $14.6K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Fluoxetine imports from India, with a total trade value of $154.4M across 389 shipments — representing a 65.6% share of all Fluoxetine exports. The average shipment value of $397.0K is above the global average of $63.6K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.

Named Fluoxetine importers in United States: AVET PHARMACEUTICALS INC C/O is the largest buyer, accounting for 73.1% ($112.8M) of this market's total imports.

• AVET PHARMACEUTICALS INC C/O — $112.8M (73.1% of United States's total)

• TORRENT PHARMA INC, — $7.9M (5.1% of United States's total)

• TIME-CAP LABS, — $2.7M (1.7% of United States's total)

Key Insight: United States's per-shipment average of $397.0K (525% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Fluoxetine imports from India.

Primary Market

Secondary Market

2Canada

Canada ranks as the second-largest destination for Fluoxetine imports from India, with a total trade value of $30.3M across 16 shipments — representing a 12.9% share of all Fluoxetine exports. The average shipment value of $1.9M is above the global average of $63.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Fluoxetine importers in Canada: ACCORD HEALTHCARE INC, is the largest buyer, accounting for 83.7% ($25.4M) of this market's total imports.

• ACCORD HEALTHCARE INC, — $25.4M (83.7% of Canada's total)

• ACCORD HEALTHCARE INC., — $2.7M (9.1% of Canada's total)

Key Insight: Canada's per-shipment average of $1.9M (2883% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Fluoxetine imports from India.

Primary Market

Secondary Market

3United Kingdom

United Kingdom ranks as the third-largest destination for Fluoxetine imports from India, with a total trade value of $19.2M across 137 shipments — representing a 8.1% share of all Fluoxetine exports. The average shipment value of $140.0K is above the global average of $63.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Fluoxetine importers in United Kingdom: BROWN AND BURK LIMITED is the largest buyer, accounting for 55.2% ($10.6M) of this market's total imports.

• BROWN AND BURK LIMITED — $10.6M (55.2% of United Kingdom's total)

• MEDREICH PLC — $2.2M (11.4% of United Kingdom's total)

Key Insight: United Kingdom's per-shipment average of $140.0K (120% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Kingdom is a key market for Fluoxetine imports from India.

Primary Market

Secondary Market

4Netherlands

Netherlands ranks as the fourth-largest destination for Fluoxetine imports from India, with a total trade value of $9.3M across 7 shipments — representing a 3.9% share of all Fluoxetine exports. The average shipment value of $1.3M is above the global average of $63.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Fluoxetine importers in Netherlands: IMRES B.V. is the largest buyer, accounting for 95.2% ($8.8M) of this market's total imports.

• IMRES B.V. — $8.8M (95.2% of Netherlands's total)

Key Insight: Netherlands's per-shipment average of $1.3M (1980% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Fluoxetine imports from India.

Primary Market

Secondary Market

5South Africa

South Africa ranks as the fifth-largest destination for Fluoxetine imports from India, with a total trade value of $3.8M across 0 shipments — representing a 1.6% share of all Fluoxetine exports. The average shipment value of $3.8M is above the global average of $63.6K, indicating high-value procurement contracts or branded formulations.

Key Insight: South Africa's per-shipment average of $3.8M (5818% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

South Africa is a key market for Fluoxetine imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Fluoxetine.
2.Flow Mapping: 253 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,702 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 101 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,702 Verified Shipments

253 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Fluoxetine

Fluoxetine

Who Supplies Fluoxetine? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Fluoxetine? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Fluoxetine Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED

2INTAS PHARMACEUTICALS LIMITED

3MICRO LABS LIMITED

4AUROBINDO PHARMA LTD

5TORRENT PHARMACEUTICALS LTD

6ALEMBIC PHARMACEUTICALS LIMITED

From Indian Factories to Global Pharmacies — How Fluoxetine Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Fluoxetine Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Canada

3United Kingdom

4Netherlands

5South Africa

People Also Ask — Fluoxetine Supplier & Trade Network

Fluoxetine Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology